21 CFR § 524.957 Ophthalmic and Topical Dosage Form New Animal Drugs

§ 524.957 Florfenicol, terbinafine, and mometasone otic solution.

Current through Sep 8, 2026 · Read all of Part 524

(a) Specifications. Each single-dose, prefilled dropperette contains 1 milliliter (mL) of a solution containing 16.6 milligrams (mg) florfenicol, 14.8 mg terbinafine (equivalent to 16.6 mg terbinafine hydrochloride), and 2.2 mg mometasone furoate.

(b) Sponsor. See Nos. 017030, 051072, and 058198 in § 510.600(c) of this chapter.

(c) Conditions of use in dogs—(1) Amount. Administer one dropperette (1 mL) per affected ear(s).

(2) Indications for use. For the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).

(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[80 FR 76387, Dec. 9, 2015, as amended at 83 FR 64740, Dec. 18, 2018; 86 FR 14821, Mar. 19, 2021; 88 FR 14901, Mar. 10, 2023; 91 FR 20342, Apr. 16, 2026]

← § 524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.§ 524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution. →